Atlas Trials

Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen

Clinical trial NCT00324610 · UNKNOWN

Trial details

NCT number
NCT00324610
Sponsor
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast NeoplasmsChemotherapy
Start date
2006-03-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.